HEADER OXIDOREDUCTASE 04-MAY-09 3HB5 TITLE BINARY AND TERNARY CRYSTAL STRUCTURES OF A NOVEL INHIBITOR OF 17 BETA- TITLE 2 HSD TYPE 1: A LEAD COMPOUND FOR BREAST CANCER THERAPY COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTRADIOL 17-BETA-DEHYDROGENASE 1; COMPND 3 CHAIN: X; COMPND 4 SYNONYM: 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1, 17-BETA-HSD 1, COMPND 5 PLACENTAL 17-BETA-HYDROXYSTEROID DEHYDROGENASE, 20 ALPHA- COMPND 6 HYDROXYSTEROID DEHYDROGENASE, 20-ALPHA-HSD, E2DH; COMPND 7 EC: 1.1.1.62 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: PROTEIN PURIFIED FROM HUMAN PLACENTA KEYWDS 17BETA-HSD1, CYTOPLASM, LIPID SYNTHESIS, NADP, OXIDOREDUCTASE, KEYWDS 2 POLYMORPHISM, STEROID BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR M.MAZUMDAR,S.-X.LIN REVDAT 2 04-APR-18 3HB5 1 REMARK REVDAT 1 15-DEC-09 3HB5 0 JRNL AUTH M.MAZUMDAR,D.FOURNIER,D.W.ZHU,C.CADOT,D.POIRIER,S.X.LIN JRNL TITL BINARY AND TERNARY CRYSTAL STRUCTURE ANALYSES OF A NOVEL JRNL TITL 2 INHIBITOR WITH 17BETA-HSD TYPE 1: A LEAD COMPOUND FOR BREAST JRNL TITL 3 CANCER THERAPY. JRNL REF BIOCHEM.J. V. 424 357 2009 JRNL REFN ISSN 0264-6021 JRNL PMID 19929851 JRNL DOI 10.1042/BJ20091020 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20578 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1084 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1440 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 76 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2177 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.188 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.171 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.135 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.862 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2305 ; 0.022 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3143 ; 2.135 ; 2.027 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 283 ; 6.664 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;37.375 ;22.283 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 371 ;19.524 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;17.430 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 367 ; 0.135 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1707 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1081 ; 0.249 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1547 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 141 ; 0.234 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 78 ; 0.295 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1465 ; 1.300 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2270 ; 2.082 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 956 ; 3.265 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 873 ; 4.776 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3HB5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-09. REMARK 100 THE DEPOSITION ID IS D_1000052918. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21662 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 19.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 0.0370 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 61.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 61.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY X 285 REMARK 465 ASP X 286 REMARK 465 VAL X 287 REMARK 465 PRO X 288 REMARK 465 ALA X 289 REMARK 465 LYS X 290 REMARK 465 ALA X 291 REMARK 465 GLU X 292 REMARK 465 ALA X 293 REMARK 465 GLY X 294 REMARK 465 ALA X 295 REMARK 465 GLU X 296 REMARK 465 ALA X 297 REMARK 465 GLY X 298 REMARK 465 GLY X 299 REMARK 465 GLY X 300 REMARK 465 ALA X 301 REMARK 465 GLY X 302 REMARK 465 PRO X 303 REMARK 465 GLY X 304 REMARK 465 ALA X 305 REMARK 465 GLU X 306 REMARK 465 ASP X 307 REMARK 465 GLU X 308 REMARK 465 ALA X 309 REMARK 465 GLY X 310 REMARK 465 ARG X 311 REMARK 465 SER X 312 REMARK 465 ALA X 313 REMARK 465 VAL X 314 REMARK 465 GLY X 315 REMARK 465 ASP X 316 REMARK 465 PRO X 317 REMARK 465 GLU X 318 REMARK 465 LEU X 319 REMARK 465 GLY X 320 REMARK 465 ASP X 321 REMARK 465 PRO X 322 REMARK 465 PRO X 323 REMARK 465 ALA X 324 REMARK 465 ALA X 325 REMARK 465 PRO X 326 REMARK 465 GLN X 327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O1N NAP X 360 O HOH X 419 1.80 REMARK 500 O7N NAP X 360 O HOH X 404 1.86 REMARK 500 O TRP X 46 O HOH X 398 2.14 REMARK 500 O GLY X 57 O HOH X 356 2.15 REMARK 500 CA ARG X 50 O HOH X 380 2.16 REMARK 500 O2D NAP X 360 O HOH X 370 2.17 REMARK 500 NZ LYS X 159 O HOH X 370 2.17 REMARK 500 N7N NAP X 360 O HOH X 404 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU X 244 CA - CB - CG ANGL. DEV. = 16.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO X 56 137.33 -38.23 REMARK 500 GLU X 81 -6.75 -55.24 REMARK 500 VAL X 115 -65.12 -108.27 REMARK 500 THR X 190 -70.89 -134.12 REMARK 500 ALA X 191 -52.19 -177.47 REMARK 500 PHE X 192 -53.59 -3.29 REMARK 500 MET X 193 48.79 -81.16 REMARK 500 GLU X 194 -27.63 -165.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 E2B X 700 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP X 360 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HB4 RELATED DB: PDB DBREF 3HB5 X 1 327 UNP P14061 DHB1_HUMAN 2 328 SEQRES 1 X 327 ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER GLY SEQRES 2 X 327 ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP PRO SEQRES 3 X 327 SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP LEU SEQRES 4 X 327 LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA LEU SEQRES 5 X 327 ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU ASP SEQRES 6 X 327 VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU ARG SEQRES 7 X 327 VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN ALA SEQRES 8 X 327 GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY GLU SEQRES 9 X 327 ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL GLY SEQRES 10 X 327 THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET LYS SEQRES 11 X 327 ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER VAL SEQRES 12 X 327 GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR CYS SEQRES 13 X 327 ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER LEU SEQRES 14 X 327 ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER LEU SEQRES 15 X 327 ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU LYS SEQRES 16 X 327 VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR ASP SEQRES 17 X 327 ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA HIS SEQRES 18 X 327 SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO GLU SEQRES 19 X 327 GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA PRO SEQRES 20 X 327 LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE LEU SEQRES 21 X 327 PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SER SEQRES 22 X 327 ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY ASP SEQRES 23 X 327 VAL PRO ALA LYS ALA GLU ALA GLY ALA GLU ALA GLY GLY SEQRES 24 X 327 GLY ALA GLY PRO GLY ALA GLU ASP GLU ALA GLY ARG SER SEQRES 25 X 327 ALA VAL GLY ASP PRO GLU LEU GLY ASP PRO PRO ALA ALA SEQRES 26 X 327 PRO GLN HET NAP X 360 48 HET E2B X 700 30 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM E2B 3-{[(9BETA,14BETA,16ALPHA,17ALPHA)-3,17-DIHYDROXYESTRA- HETNAM 2 E2B 1,3,5(10)-TRIEN-16-YL]METHYL}BENZAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 E2B C26 H31 N O3 FORMUL 4 HOH *94(H2 O) HELIX 1 1 SER X 12 SER X 24 1 13 HELIX 2 2 ASP X 38 THR X 41 5 4 HELIX 3 3 GLN X 42 LEU X 52 1 11 HELIX 4 4 ASP X 68 ARG X 78 1 11 HELIX 5 5 PRO X 98 LEU X 102 5 5 HELIX 6 6 GLY X 103 VAL X 115 1 13 HELIX 7 7 VAL X 115 GLY X 133 1 19 HELIX 8 8 GLY X 144 LEU X 146 5 3 HELIX 9 9 ASN X 152 LEU X 174 1 23 HELIX 10 10 SER X 199 ASP X 205 1 7 HELIX 11 11 ASP X 208 ALA X 230 1 23 HELIX 12 12 ASN X 232 ALA X 246 1 15 HELIX 13 13 PHE X 259 ASP X 269 1 11 HELIX 14 14 GLY X 272 PHE X 284 1 13 SHEET 1 A 7 LEU X 59 GLN X 63 0 SHEET 2 A 7 PHE X 30 LEU X 36 1 N VAL X 32 O GLU X 60 SHEET 3 A 7 THR X 3 ILE X 7 1 N VAL X 5 O TYR X 33 SHEET 4 A 7 VAL X 86 CYS X 89 1 O VAL X 88 N LEU X 6 SHEET 5 A 7 GLY X 135 SER X 142 1 O LEU X 138 N LEU X 87 SHEET 6 A 7 VAL X 178 CYS X 185 1 O HIS X 179 N VAL X 137 SHEET 7 A 7 ARG X 252 PHE X 254 1 O TYR X 253 N GLU X 184 SITE 1 AC1 29 GLY X 9 CYS X 10 SER X 11 SER X 12 SITE 2 AC1 29 ILE X 14 GLY X 15 THR X 35 LEU X 36 SITE 3 AC1 29 ARG X 37 LEU X 64 ASP X 65 VAL X 66 SITE 4 AC1 29 ARG X 67 ASN X 90 ALA X 91 GLY X 92 SITE 5 AC1 29 THR X 140 GLY X 141 TYR X 155 LYS X 159 SITE 6 AC1 29 CYS X 185 GLY X 186 VAL X 188 THR X 190 SITE 7 AC1 29 PHE X 192 HOH X 344 HOH X 370 HOH X 404 SITE 8 AC1 29 HOH X 419 CRYST1 123.200 44.000 60.800 90.00 100.30 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008117 0.000000 0.001475 0.00000 SCALE2 0.000000 0.022727 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016717 0.00000 MASTER 369 0 2 14 7 0 8 6 0 0 0 26 END